Transaction · 0000919574-26-006609

GordonMD Global Investments LP

GordonMD Global Investments LP, 10%, reported an open-market or private purchase at Pyxis Oncology, Inc. involving 7546766.000000 shares. Reported holdings after the transaction were 7546766.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code P10%
PYXSPyxis Oncology, Inc.
Filing timeOct 02
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$2.19
Pre-filing
1mo ago +57.1%1w ago +33.3%1d ago +6.4%
Returns since
7d30d90d180d1y

PYXS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PYXS since 2026-10-02Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
Buy
Code P
Identifier
0000919574-26-006609
Common Stock Purchase Warrant
Transaction date
Oct 01, 2026
Filed Oct 02, 2026, 12:35 PM · 1d delay
Shares
7.54M sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
7.54M sh
Indirect · See footnote

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Large Holdings Increase 10% Owner Buy
+4score
Filing-only score

+4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    The securities to which this filing relates are held directly by GordonMD Long Biased Master Fund LP (the "Master Fund") to which GordonMD Global Investments LP (the "Investment Manager") serves as in…

  2. F2

    The combined public offering price for each share of common stock and accompanying Common Stock Purchase Warrant is $2.90.

  3. F3

    Exercise price of $3.5, subject to adjustments as set forth in the Common Stock Purchase Warrant.

  4. F4

    The Common Stock Purchase Warrant will not be exercisable unless and until (i) the issuer's stockholders approve an amendment to the issuer's amended and restated certificate of incorporation to incre…

  5. F5

    The Common Stock Purchase Warrant will expire on the earlier of (i) the fifth anniversary of the Charter Amendment Effective Date and (ii) the 30th calendar day following the later of the Charter Amen…

Original filing · 0000919574-26-006609
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PYXS